TWO SIMILAR ADVERSE EVENTS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AFTER RITUXIMAB THERAPY

被引：0
|
作者：
Elfving, P. [1 ]
Kononoff, A. [1 ]
Kaipiainen-Seppanen, O. [1 ]
机构：
[1] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2009年 / 38卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：405 / 405
页数：1
相关论文
共 50 条
  • [41] Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
    Medha Barbhaiya
    Jonah M. Levine
    Caroline H. Siegel
    Vivian P. Bykerk
    Deanna Jannat-Khah
    Lisa A. Mandl
    Clinical Rheumatology, 2022, 41 : 1619 - 1622
  • [42] Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
    Barbhaiya, Medha
    Levine, Jonah M.
    Siegel, Caroline H.
    Bykerk, Vivian P.
    Jannat-Khah, Deanna
    Mandl, Lisa A.
    CLINICAL RHEUMATOLOGY, 2022, 41 (05) : 1619 - 1622
  • [43] Incidence of and Risk Factors for Adverse Cardiovascular Events Among Patients With Systemic Lupus Erythematosus
    Magder, Laurence S.
    Petri, Michelle
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 176 (08) : 708 - 719
  • [44] LONG-TERM DATA ON RITUXIMAB AND BELIMUMAB THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Nikishina, N.
    Mesnyankina, A.
    Aseeva, E.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S456 - S456
  • [45] LONG-TERM RESULTS OF THERAPY WITH RITUXIMAB AND BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Issayeva, B.
    Mesnyankina, A.
    Aseeva, E.
    Nikishina, N.
    Issayeva, S.
    Saparbayeva, M.
    Bizhanova, M.
    Amanzholova, A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S181 - S181
  • [46] ADVERSE PREGNANCY OUTCOMES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE ROLE OF THERAPY.
    Cilona, M. B.
    Canti, V.
    Dalpiaz, I.
    De Lorenzo, R.
    Inguscio, G.
    Asperti, C.
    Rosa, S.
    Castiglioni, M. T.
    Rovere-Querini, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1352 - 1352
  • [47] RITUXIMAB USE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: THE EXPERIENCE OF TWO CENTRAL HOSPITALS IN LISBON
    Goncalves, M. J.
    Sousa, S.
    Saavedra, M. J.
    Ramos, F.
    Fonseca, J. E.
    Pereira da Silva, J. A.
    da Silva, C.
    Macieira, C.
    Santos, M. J.
    Canhao, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 902 - 903
  • [48] Rituximab for severe systemic lupus erythematosus
    Carrillo-Vàzquez, M
    Reyes-Salinas, A
    Saavedra-Salinas, MA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 248 - 248
  • [49] RESPONSIVENESS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AFTER RITUXIMAB TREATMENT: A SINGLE CENTER EXPERIENCE
    Tsao, Y. P.
    Tsai, C. Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1215 - 1215
  • [50] Lymphoid follicular hyperplasia in patients with systemic lupus erythematosus after multiple cycles of rituximab
    Ruiz-Ordonez, Ingrid
    Santos, Victor A.
    Bonilla-Abadia, Fabio
    Silva, Nhora
    Sanchez, Aura
    Tobon, Gabriel J.
    Canas, Carlos A.
    MODERN RHEUMATOLOGY CASE REPORTS, 2023, 7 (01) : 78 - 81
12345